Marrone Bio Announces CFO Transition
22 Febbraio 2022 - 10:30PM
Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international
leader in sustainable bioprotection and plant health solutions,
announced today a transition of its Chief Financial Officer role.
Current CFO Sue Cheung has chosen to resign for personal reasons,
effective March 9, 2022. LaDon Johnson, a director with CFO
Systems, has been appointed interim CFO on a consulting basis while
the company begins a national search for a permanent CFO.
“We appreciate Sue’s contributions to Marrone
Bio over the past year, and wish her the best,” said Chief
Executive Officer Kevin Helash. “I have full confidence in LaDon
and our finance organization, and expect the transition to be
seamless.”
Mr. Johnson has more than 30 years of experience
in global corporate finance in the agriculture, food, renewables
and biotechnology sectors. Previous roles include serving as CFO
for an international biotechnology company and as Managing Director
and CFO for the fifth largest crop seed company in the world.
Helash added, “We welcome LaDon to the company
and look forward to gaining from his insights and experience in
finance for global agricultural companies during the coming months
as we manage the transition and recruit a permanent CFO.”
About Marrone Bio
Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII)
is a growth-oriented agricultural company leading the movement to
environmentally sustainable farming practices through the
discovery, development and sale of innovative biological products
for crop protection, crop health and crop nutrition. Our portfolio
of 18 products helps customers operate more sustainably while
increasing their return on investment. The company’s commercial
products are sold globally and supported by a robust portfolio of
more than 500 issued and pending patents. Our end markets include
row crops; fruits and vegetables; trees, nuts and vines; and
greenhouse production. Marrone Bio’s research and development
program uses proprietary technologies to isolate and screen
naturally occurring microorganisms and plant extracts to create
new, environmentally sound solutions in agriculture.
Learn more about Marrone Bio Innovations at
www.marronebio.com. We also use our investor relations website,
https://investors.marronebio.com, as well as our corporate Twitter
account, @Marronebio, as means of disclosing material non-public
information, and encourage our investors and others to monitor and
review the information we make public in these locations. Follow us
on social media: Twitter, LinkedIn and Instagram.
Marrone Bio Innovations Forward Looking
Statements
This press release contains forward-looking
statements within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, included in this press release regarding the timing of Ms.
Cheung’s departure and the transition of Mr. Johnson as interim
CFO, including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing the company’s views as of any subsequent
date. Such forward-looking statements are based on
information available to the company as of the date of this release
and involve a number of risks and uncertainties, some beyond the
company’s control, that could cause actual results to differ
materially from those anticipated by these forward-looking
statements, including the recent uncertainty in the global economy
and industry-specific economy caused by the COVID-19 pandemic,
consumer, regulatory, weather and other factors affecting demand
for the company’s products, any difficulty in expanding the
company’s sales and marketing infrastructure or marketing the
company’s products in global markets, competition in the market for
herbicide products, lack of understanding of bio-based herbicide
products by customers and growers, adverse actions by distributors,
manufacturers, regulatory agencies and other relevant third
parties. Additional information that could lead to material changes
in the company’s performance is contained in its filings with the
Securities and Exchange Commission. The company is under no
obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of new information, future events or
otherwise.
Marrone Bio Innovations Contact:Clyde
MontevirgenVice President of Business Development & Investor
RelationsTelephone: 530-750-2800info@marronebio.com
Grafico Azioni Marrone Bio Innovations (NASDAQ:MBII)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Marrone Bio Innovations (NASDAQ:MBII)
Storico
Da Giu 2023 a Giu 2024